Pegvisomant treatment in acromegaly in clinical practice: Final results of the French ACROSTUDY (312 patients)-Reference-Cited by-同舟云学术

Pegvisomant treatment in acromegaly in clinical practice: Final results of the French ACROSTUDY (312 patients)

Published:2021-12 Issue:6 Volume:82 Page:582-589
ISSN:0003-4266
Container-title:Annales d'Endocrinologie
language:en
Short-container-title:Annales d'Endocrinologie

Author:

Barraud Sara,Caron Philippe,Raingeard Isabelle,Lefebvre Hervé,Raverot Gérald,Cortet-Rudelli Christine,Desailloud Rachel,Henocque Robin,Brault Yves,Brue Thierry,Chanson Philippe,Delemer Brigitte

Funder

Pfizer Foundation

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference23 articles.

1. Epidemiology of acromegaly: review of population studies;Lavrentaki;Pituitary,2017

2. Medical progress: acromegaly;Melmed;N Engl J Med,2006

3. Acromegaly;Chanson;Orphanet J Rare Dis,2008

4. French consensus on the management of acromegaly;Chanson;Ann Endocrinol,2009

5. Acromegaly: an endocrine society clinical practice guideline;Katznelson;J Clin Endocrinol Metab,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment of acromegaly – When the tumor size matters: A narrative review;Growth Hormone & IGF Research;2024-10

2. Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis;Endocrine Connections;2024-01-10

3. Treatment Patterns, Adherence, Persistence, and Health Care Resource Utilization in Acromegaly: A Real-World Analysis;Journal of the Endocrine Society;2023-08-23

4. Preference of acromegaly patients for treatment attributes in Spain;Endocrine;2023-07-28

5. Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly;Endocrine;2022-08-20